(BQ) Part 1 book "Principles and practice of PET and PET/CT" presents the following contents: Production of radionuclides for PET, PET physics and PET instrumentation, radiotracer chemistry, data analysis and image processing, fundamentals of CT in PET/CT, standardized uptake values, image fusion, oncologic applications,...
Molecular cloning has identified eight metabotropic glutamate receptor (mGluR)
subtypes, each with distinct patterns of expression. However, the characteristic roles of
these different mGluRs in physiological processes are not well understood.
Identification of subtype-specific compounds may potentially act as therapeutic agents
for the treatment of a wide range of conditions (including progressive brain disease,
epilepsy and cerebral ischemia) all of which are associated with abnormal mGLuR
The field of molecular imaging/nuclear medicine continues to build excitement
for the medical community as a whole. To be able to visualize fundamental
molecular and biochemical processes in patients in a meaningful way has truly
become reality. Of all the available molecular probes and tools it is clear that
FDG with PET-CT is one of the true clinical success stories. Very few would
have been able to predict the eventual impact of a simple glucose analog as a
marker for imaging cancer, hibernating myocardium, Alzheimer’s disease,
epilepsy and many other important disease processes....
There have been several significant advances innuclearmedicine since the publication of the
second edition of Practical NuclearMedicine. The last seven years have seen great strides in
instrumentation, including new coincidence detectors, the development of a wider variety
of crystals, and the advent of combined anatomical/functional imaging devices, including
PET/CT and SPECT/CT. PET imaging with 18F-FDG has become a mainstay of many
clinical settings, and other radiotracers are finding theirway into the rapidly expanding field
of oncologic PET.